In the context of new anti-obesity medications, the American College of Cardiology has issued a Scientific Statement updating ...

Millions more Americans should be taking weight-loss drugs to prevent heart disease, according to the American College of ...

Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.

Background and objective Prior studies have suggested that patients with premature ventricular complexes (PVCs) may have an ...

Obesity involves having too much body fat. According to the Mayo Clinic, obesity becomes a medical problem that increases the risk of many other diseases and health problems.These problems include ...

Shares of weight-loss drugmakers Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) spiked after the American College of Cardiology ...

Snacking on walnuts instead of biscuits or sweets may add years to your life, according to research. A handful a day reduces ...

Policymakers must prioritize access to innovative obesity care in tackling the obesity epidemic across the United States.

Explore the critical links between angina and heart disease in women in India, highlighting expert insights, health awareness ...

In PAH, 5-year mortality is similar with and without obesity, even though patients with obesity have more comorbidities and worse functional capacity.

This June, like every other, has been filled with talk of graduations, the scent of barbecue and Fathers' Day sales. But amid all the hype, we need to remember that June is also Men's Health Month—a ...

Amgen is expanding development plans for its weight-loss drug MariTide to study its use for heart disease and sleep apnea.